Journal article
Apixaban
Hospital pharmacy (Philadelphia), Vol.48(6), pp.494-509
06/2013
Handle:
https://hdl.handle.net/2376/104226
PMCID: PMC3839491
PMID: 24421512
Abstract
Each month, subscribers to
The Formulary Monograph Service
receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. A drug class review is now published monthly with
The Formulary Monograph Service.
Through the cooperation of
The Formulary, Hospital Pharmacy
publishes selected reviews in this column. For more information about
The Formulary Monograph Service,
call
The Formulary
at 800-322-4349. The June 2013 monograph topics are dimethyl fumarate (BG-12) delayed-release capsules, canagliflozin, ospemifene, aripiprazole extended-release injectable, and dabrafenib. The DUE/MUE is on dimethyl fumarate.
Metrics
19 Record Views
Details
- Title
- Apixaban
- Creators
- Dennis J Cada - Executive EditorTerri L Levien - Clinical Associate Professor of Pharmacotherapy, Drug Information Center, Washington State University, Spokane, WashingtonDanial E Baker - Director, Drug Information Center, and Professor of Pharmacy Practice, College of Pharmacy, Washington State University Spokane, PO Box 1495, Spokane, Washington 99210-1495
- Publication Details
- Hospital pharmacy (Philadelphia), Vol.48(6), pp.494-509
- Academic Unit
- Pharmacotherapy, Department of
- Publisher
- Thomas Land Publishers, Inc
- Identifiers
- 99900546730601842
- Language
- English
- Resource Type
- Journal article